OQROStart free trial
Politician trade (House)

Abbott Laboratories (ABT): Rep. Pete Sessions (TX17) disclosed a sale $50K–$100K

Rep. Pete Sessions (TX17) disclosed a sale of Abbott Laboratories in the $50K–$100K range.

$50,001–$100,000
Reported range · official band, not an exact amount
25 days
Disclosure lag
Traded
Oct 2, 2026
Disclosed
Oct 27, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 14, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
  2. Jul 17, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  3. Jul 30, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  4. Aug 6, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
  5. Aug 11, 2026InsiderOfficer sold ~$643K of ABT shares in the open market
  6. Aug 20, 2026FDARecall: Fisher Scientific Sure-Vue Serum/Urine hCG, Model/ Part: FHC-202/23900529, FHC-202/23900528; Beckman Coulter Inc's ICON 25 hCG, Model/ Part: FHC-202/43025; Hen…
  7. Aug 20, 2026FDARecall: Fisher Scientific Sure-Vue Urine hCG, Model/ Part: FHC-102/23900526; Henry Schein, Inc. One Step + Urine Cassette Test, Model/ Part: FHC-102/9004074, FHC-102/9…
  8. Aug 20, 2026FDARecall: McKesson CONSULT hCG Urine Cassette, Model/ Part: FHC-A102/5001; Alere hCG Cassette (20 mIU/mL) in Urine, Model/ Part: FHC-A102/92210; Fisher Scientific Sure-V…
  9. Aug 20, 2026FDARecall: Fisher Scientific Sure-Vue Urine hCG Strip, Model/ Part: FHC-101/23900527; McKesson CONSULT hCG Urine Test Dipstick CLIA Waived, Model/ Part:FHC-101/5000; Henr…
  10. Aug 25, 2026Insider · 1 personInsiders: 2 sales (~$46.2M)
  11. Sep 2, 2026InsiderOfficer sold ~$3K of ABT shares in the open market
  12. Sep 17, 2026FDAFDA device clearance: EnSite™ X EP System
  13. Sep 18, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  14. Sep 23, 2026FDAFDA device clearance: Anti-HCV Next
  15. Oct 2, 2026 · this disclosureCongressDisclosed sale of ABT — reported range $50,001 - $100,000

What came next

  1. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Pete Sessions (TX17)

The full history of Rep. Pete Sessions (TX17) is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data